Cardiovascular Syst (CSII) 19.50 $CSII
Cardiovascular Systems Up 88.6% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri Jul 29, 12:13AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 5 months, Cardiovascular Systems has returned 88.61% as of today's recent price of $19.30.
CSII: 19.50 (-0.11)
Uptrend Call Working As Cardiovascular Systems Stock Rises 86.6% (CSII)
Comtex SmarTrend(R) - Thu Jul 14, 12:11AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 86.61% as of today's recent price of $19.09.
CSII: 19.50 (-0.11)
Cardiovascular Systems Seeks Device Approval in Japan
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 7:49AM CDT
On receiving the approval, Japan will become the first international market to offer a product of Cardiovascular Systems (CSII).
HCM: 13.19 (+0.06), CSII: 19.50 (-0.11), GWPH: 96.11 (+1.79), NUVA: 63.29 (+1.09)
Cardiovascular Systems Submits Diamondback 360(R) Coronary Orbital Atherectomy System Micro Crown for Approval in Japan
BusinessWire - Wed Jul 06, 3:05PM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has submitted an application to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for approval of its Diamondback 360(R) Coronary Orbital Atherectomy System (OAS) Micro Crown to treat severely calcified coronary arteries for the facilitation of stent placement.
CSII: 19.50 (-0.11)
84.8% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Wed Jul 06, 12:44PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 84.75% as of today's recent price of $18.90.
CSII: 19.50 (-0.11)
Cardiovascular Systems Has Returned 66.0% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 21, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 65.98% as of today's recent price of $16.98.
CSII: 19.50 (-0.11)
Cardiovascular Systems Shares Up 78.3% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 14, 12:12AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 78.30% as of today's recent price of $18.24.
CSII: 19.50 (-0.11)
FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
PR Newswire - Fri Jun 10, 10:30AM CDT
Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully completed the second and final phase of its work plan to remediate all products manufactured or distributed from Terumo's Ann Arbor, Michigan manufacturing facility, including Terumo® Advanced Perfusion System 1. As a result, all shipping restrictions, imposed as a term of its 2011 consent decree, are now lifted.
CSII: 19.50 (-0.11)
Cardiovascular Systems Up 70.3% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri May 27, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 70.28% as of today's recent price of $17.42.
CSII: 19.50 (-0.11)
Cardiovascular Systems Shares Up 42.4% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Thu May 12, 1:03PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 42.42% as of today's recent price of $14.57.
CSII: 19.50 (-0.11)
Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
PR Newswire - Thu May 12, 12:07PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company"
(NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders.
CSII: 19.50 (-0.11)
Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.58 (-0.12), CSII: 19.50 (-0.11), BAX: 48.50 (+0.48), CRDC: 2.35 (-0.15)
Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting
BusinessWire - Thu May 05, 7:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
CSII: 19.50 (-0.11)
Shares of CSII Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 05, 12:54AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 33.63% as of today's recent price of $13.67.
CSII: 19.50 (-0.11)
Cardiovascular Systems reports 3Q loss
Automated Insights - Wed May 04, 5:06PM CDT
ST. PAUL, Minn. (AP) _ Cardiovascular Systems Inc. (CSII) on Wednesday reported a loss of $22.7 million in its fiscal third quarter.
CSII: 19.50 (-0.11)
Cardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial Results
BusinessWire - Wed May 04, 3:05PM CDT
--Revenues of $44.5 million grew 7% from second quarter of fiscal 2016
CSII: 19.50 (-0.11)
Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 24.43 (+0.15), CAPR: 3.58 (-0.12), CSII: 19.50 (-0.11), ABAX: 49.14 (-0.32)
NuVasive (NUVA) Tops Q1 Earnings, Grows Internationally
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 11:03AM CDT
NuVasive, Inc. (NUVA) reported first-quarter 2016 adjusted earnings per share (EPS) of 32 cents.
BSX: 24.43 (+0.15), CSII: 19.50 (-0.11), STJ: 83.73 (+0.69), NUVA: 63.29 (+1.09)
Cardiovascular Systems Up 88.6% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri Jul 29, 12:13AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 5 months, Cardiovascular Systems has returned 88.61% as of today's recent price of $19.30.
CSII: 19.50 (-0.11)
Uptrend Call Working As Cardiovascular Systems Stock Rises 86.6% (CSII)
Comtex SmarTrend(R) - Thu Jul 14, 12:11AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 86.61% as of today's recent price of $19.09.
CSII: 19.50 (-0.11)
Cardiovascular Systems Seeks Device Approval in Japan
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 7:49AM CDT
On receiving the approval, Japan will become the first international market to offer a product of Cardiovascular Systems (CSII).
HCM: 13.19 (+0.06), CSII: 19.50 (-0.11), GWPH: 96.11 (+1.79), NUVA: 63.29 (+1.09)
Cardiovascular Systems Submits Diamondback 360(R) Coronary Orbital Atherectomy System Micro Crown for Approval in Japan
BusinessWire - Wed Jul 06, 3:05PM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has submitted an application to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for approval of its Diamondback 360(R) Coronary Orbital Atherectomy System (OAS) Micro Crown to treat severely calcified coronary arteries for the facilitation of stent placement.
CSII: 19.50 (-0.11)
84.8% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Wed Jul 06, 12:44PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 84.75% as of today's recent price of $18.90.
CSII: 19.50 (-0.11)
Cardiovascular Systems Has Returned 66.0% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 21, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 4 months, Cardiovascular Systems has returned 65.98% as of today's recent price of $16.98.
CSII: 19.50 (-0.11)
Cardiovascular Systems Shares Up 78.3% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Tue Jun 14, 12:12AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 78.30% as of today's recent price of $18.24.
CSII: 19.50 (-0.11)
FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
PR Newswire - Fri Jun 10, 10:30AM CDT
Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully completed the second and final phase of its work plan to remediate all products manufactured or distributed from Terumo's Ann Arbor, Michigan manufacturing facility, including Terumo® Advanced Perfusion System 1. As a result, all shipping restrictions, imposed as a term of its 2011 consent decree, are now lifted.
CSII: 19.50 (-0.11)
Cardiovascular Systems Up 70.3% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri May 27, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 70.28% as of today's recent price of $17.42.
CSII: 19.50 (-0.11)
Cardiovascular Systems Shares Up 42.4% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Thu May 12, 1:03PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 42.42% as of today's recent price of $14.57.
CSII: 19.50 (-0.11)
Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
PR Newswire - Thu May 12, 12:07PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company"
(NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders. CSII: 19.50 (-0.11)
Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.58 (-0.12), CSII: 19.50 (-0.11), BAX: 48.50 (+0.48), CRDC: 2.35 (-0.15)
Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting
BusinessWire - Thu May 05, 7:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
CSII: 19.50 (-0.11)
Shares of CSII Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 05, 12:54AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 33.63% as of today's recent price of $13.67.
CSII: 19.50 (-0.11)
Cardiovascular Systems reports 3Q loss
Automated Insights - Wed May 04, 5:06PM CDT
ST. PAUL, Minn. (AP) _ Cardiovascular Systems Inc. (CSII) on Wednesday reported a loss of $22.7 million in its fiscal third quarter.
CSII: 19.50 (-0.11)
Cardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial Results
BusinessWire - Wed May 04, 3:05PM CDT
--Revenues of $44.5 million grew 7% from second quarter of fiscal 2016
CSII: 19.50 (-0.11)
Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 24.43 (+0.15), CAPR: 3.58 (-0.12), CSII: 19.50 (-0.11), ABAX: 49.14 (-0.32)
NuVasive (NUVA) Tops Q1 Earnings, Grows Internationally
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 11:03AM CDT
NuVasive, Inc. (NUVA) reported first-quarter 2016 adjusted earnings per share (EPS) of 32 cents.
BSX: 24.43 (+0.15), CSII: 19.50 (-0.11), STJ: 83.73 (+0.69), NUVA: 63.29 (+1.09)
